Anhedonia revisited: is there a role for dopamine-targeting drugs for depression?
about
On the Complexity of Brain Disorders: A Symptom-Based Approach.Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.Reduction in ventral striatal activity when anticipating a reward in depression and schizophrenia: a replicated cross-diagnostic finding.Investigating the Predictive Value of Functional MRI to Appetitive and Aversive Stimuli: A Pattern Classification ApproachIndividual Variations in Nucleus Accumbens Responses Associated with Major Depressive Disorder Symptoms.Abnormal Frontostriatal Activity During Unexpected Reward Receipt in Depression and Schizophrenia: Relationship to AnhedoniaModeration of the Relationship Between Reward Expectancy and Prediction Error-Related Ventral Striatal Reactivity by Anhedonia in Unmedicated Major Depressive Disorder: Findings From the EMBARC Study.Dextroamphetamine and Pramipexole Combination for Treatment-Resistant Unipolar DepressionEffort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review.The biological effects of childhood trauma.The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.A Case of Electroconvulsive Therapy-Resistant Depression Responding to Multiple Dopaminergic Medications.Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder.Blunted neural response to anticipation, effort and consummation of reward and aversion in adolescents with depression symptomatology.Enhanced neural response to anticipation, effort and consummation of reward and aversion during bupropion treatment.The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.Antidepressant-induced Dopamine Receptor Dysregulation: A Valid Animal Model of Manic-Depressive Illness.Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.
P2860
Q30389213-E43921C0-C251-471C-A3E2-E608946BDF86Q35150163-446F0BB8-3906-4731-8B9F-FAB315CFF5AAQ35203638-13CE011A-CC3A-4E81-A5AC-F686FD0D24CAQ35996129-F80C58B8-8DB7-4DD3-8ACC-1D0D8B1FB324Q36199688-A93017AF-3A81-4A29-92BA-023D2FFDA5E2Q36583571-C5BE8937-2292-4F55-B203-332228E27788Q36763174-473492A5-D0D2-4790-95D3-0B9DD7D5BEF6Q36873917-A3B9B3A2-D763-4932-BD3A-D3025A988C03Q37275896-80EB0CE4-F483-420F-ADBE-8A3D8F49BCDDQ37362447-C700F759-0342-4E50-8DD3-133D4FC7E9FFQ37424327-6F8D490B-A0CA-4D51-A891-D15C80CDEC38Q37633236-002FD463-9EFE-462D-9E8E-FA8D0A31B8ACQ37669920-C74FDB51-BB3C-49A9-853D-59102EF902B0Q39758341-BEDE14E1-C63D-4CBE-ACBC-05A65DC17E3FQ43097997-5484A85E-21AD-4B6E-BDB5-776674B81080Q47157142-C80518AE-55DC-4535-923D-1936FA23ECC1Q47353134-ED8463A5-07AD-4148-972A-79EC5884C11FQ48055209-011619D9-F1C5-4C0F-A4EB-04F9BBCF4323Q48190081-A49B4F81-59ED-44B4-87B3-6891E3FAF11DQ53610589-32E5B7AB-AA19-4B71-AB9C-6EDF06B542B8Q55132660-0D1AFD23-E551-454C-8DE9-1AC278033E0A
P2860
Anhedonia revisited: is there a role for dopamine-targeting drugs for depression?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Anhedonia revisited: is there a role for dopamine-targeting drugs for depression?
@en
type
label
Anhedonia revisited: is there a role for dopamine-targeting drugs for depression?
@en
prefLabel
Anhedonia revisited: is there a role for dopamine-targeting drugs for depression?
@en
P2860
P356
P1476
Anhedonia revisited: is there a role for dopamine-targeting drugs for depression?
@en
P2093
Spilios V Argyropoulos
P2860
P304
P356
10.1177/0269881113494104
P407
P50
P577
2013-07-31T00:00:00Z